T1	Participants 577 613	171 children with standard-risk ALL,
T2	Participants 870 878	Patients
T3	Participants 1141 1187	19.5% of children in the IT methotrexate group
T4	Participants 1854 1862	patients
T5	Participants 876 941	ts who received IT methotrexate had a mean Processing Speed Index
